Related Experiment Video
Updated: Jun 5, 2025

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
CD14loCD301b+ macrophages gathering as a proangiogenic marker in adipose tissues
Yibing Lv1, Yidan Zheng2, Shanshan Su3
1Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The role of the monocyte marker CD14 in the regulation of obesity is increasingly recognized. Our observations indicated that Cd14-/- mice exhibited a leaner body shape compared to their wild-type (WT) counterparts. And the loss of CD14 alleviated high-fat diet-induced obesity in mice. In human subjects, CD14 level was tested to be positively correlated with overweight and obesity. However, the relationship between CD14 and the development of obesity remains only partially understood. To investigate the underlying mechanisms, adipose tissues (ATs) from Cd14-/- and WT mice were subjected to deep RNA sequencing. Gene Ontology enrichment analysis revealed a significant enhancement of angiogenesis-related function in the Cd14-/- epididymal adipose tissues compared to WT counterpart, which was accompanied by an upregulation of Cd301b. Subsequent assays confirmed the enhanced angiogenesis and more accumulation of CD301b+ macrophages in Cd14-/- epididymal adipose tissues. Because Igf1 expression has been suggested to be associated with Cd301b expression through pseudotime analysis, we found it was insulin-like growth factor 1 secreted from Cd14-/- macrophages that mediated the angiogenesis enhancement. Collectively, our findings indicate that CD14 deficiency increased the accumulation of CD14loCD301b+ macrophages in ATs, which may serve as a proangiogenic marker, providing novel insights into the relationship between CD14 and obesity development.
Insights
CD14 deficiency leads to leaner mice and reduced obesity. Loss of CD14 promotes CD14loCD301b+ macrophage accumulation, enhancing blood vessel growth (angiogenesis) in adipose tissue.
Area of Science:
- Metabolism and Endocrinology
- Immunology
- Molecular Biology
Background:
- The monocyte marker CD14 is implicated in obesity regulation.
- CD14 levels correlate positively with overweight and obesity in humans.
- The precise mechanisms linking CD14 to obesity development require further elucidation.
Purpose of the Study:
- To investigate the role of CD14 in obesity using a mouse model.
- To explore the molecular mechanisms underlying CD14's influence on adipose tissue.
- To identify potential biomarkers associated with CD14 and obesity.
Main Methods:
- Comparative analysis of adipose tissues from CD14 knockout (Cd14-/-) and wild-type (WT) mice using deep RNA sequencing.
- Gene Ontology enrichment analysis to identify functional pathways.
- Assays to confirm angiogenesis and macrophage accumulation.
- Pseudotime analysis to investigate gene expression relationships.
Main Results:
- Cd14-/- mice were leaner and resistant to high-fat diet-induced obesity compared to WT mice.
- Enhanced angiogenesis and increased CD301b+ macrophage accumulation were observed in Cd14-/- adipose tissues.
- Insulin-like growth factor 1 (Igf1) secreted by Cd14-/- macrophages mediated the proangiogenic effect.
Conclusions:
- CD14 deficiency promotes the accumulation of CD14loCD301b+ macrophages in adipose tissue.
- These macrophages may act as proangiogenic markers.
- The findings offer new insights into the CD14-obesity relationship and potential therapeutic targets.
More Related Videos
07:32Characterization of Immune Cells in Human Adipose Tissue by Using Flow Cytometry
Published on: March 6, 2018
06:22Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
Published on: October 27, 2020